Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

CBD: Cooperation to Outdo Competition

At the CPA 2020 Annual Meeting, Bruce Bernstein, President of UBIX Processing, talks about the opportunities for CPGs and contract packagers in the growing CBD market.

AM Mohan
Anne Marie Mohan, Editor, Contract Packaging magazine

Much attention has been given to the business opportunities around legalized medical and recreational marijuana. However, there has been less “buzz” (pun intended) about CBD, or cannabidiol, and the emerging market for CBD products.

At the CPA 2020 Annual Meeting in February, Bruce Bernstein, President of UBIX Processing, took the stage to provide clarity on CBD. UBIX is a co-pack/co-man of CBD products, including capsules, tinctures, gummy drops, salve, vape oil, and more. Said Bernstein, who is prostate cancer-free after treating the disease with CBD, “People should know this is a powerful compound for good.”

CBD is essentially industrial hemp, a compound of cannabis that contains less than 0.3% of the psychoactive component of marijuana, or THC, thus it does not produce a “high.” According to Bernstein, CBD provides relief for neurological, gastrointestinal, mood and behavior, pain, and sleep conditions, among other health issues, and is one of the most effective natural anti-inflammatory compounds available.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?